[1]
Y. Zhao, “Protective mechanism and clinical application of SGLT2 inhibitors in patients with type 2 diabetes mellitus complicated with abnormal liver function”, IJPHMR, vol. 1, no. 1, pp. 35–45, Mar. 2024, doi: 10.62051/ijphmr.v1n1.05.